For the Inventor, By the Inventor

Enter assignee name

Salt Lake City, UT, United States of America

Theratech, Inc.

USPTO Granted Patents = 36

CIPO Patents = 1

EPO Patents = 2

Trademarks = 2

Forward Citations = 3,142

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Charles D Ebert (24 out of 44 patents)

Dinesh C Patel (13 out of 13 patents)

Srinivasan Venkateshwaran (12 out of 38 patents)

4. Sonia J Heiber (9 out of 9 patents)

5. Yunik Chang (4 out of 5 patents)

6. Werner Heiber (3 out of 3 patents)

7. Mark K Gutniak (3 out of 3 patents)

8. David Fikstad (3 out of 3 patents)

9. Danyi Quan (2 out of 10 patents)

10. Ramesh K Prakash (2 out of 4 patents)

11. Jan Feijen (2 out of 2 patents)

12. Ramesh N Acharya (2 out of 7 patents)

13. Sirish C Dave (2 out of 2 patents)

14. Ninad A Deshpanday (2 out of 2 patents)

15. Sonal R Patel (2 out of 2 patents)

Core Competencies:

Transdermal Delivery

Buccal Delivery

Penetration Enhancers

Controlled Release

Drug Delivery Compositions

Hydrogel Matrices

Iontophoresis

Skin Permeation

Pharmaceutical Agents

Noninvasive Monitoring

Appetite Control

Stability of Steroids

36 patents: Sort by Forward Citations

1. 5985317 - Pressure sensitive adhesive matrix patches for transdermal delivery of (1999-11-16),

2. 5952000 - Fatty acid esters of lactic acid salts as permeation enhancers (1999-09-14),

3. 5912009 - Fatty acid esters of glycolic acid and its salts (1999-06-15),

4. 5863555 - Buccal delivery of glucagon-like insulinotropic peptides (1999-01-26),

5. 5849322 - Compositions and methods for buccal delivery of pharmaceutical agents (1998-12-15),

6. 5834010 - Triacetin as a penetration enhancer for transdermal delivery of a basic (1998-11-10),

7. 5783208 - Transdermal drug delivery matrix for coadministering estradiol and (1998-07-21),

8. 5780050 - Drug delivery compositions for improved stability of steroids (1998-07-14),

9. 5766620 - Buccal delivery of glucagon-like insulinotropic peptides (1998-06-16),

10. 5762953 - Transdermal propentofylline compositions for the treatment of Alzheimers (1998-06-09),

11. 5686094 - Controlled release formulations for the treatment of xerostomia (1997-11-11),

12. 5662925 - Transdermal delivery system with adhesive overlay and peel seal disc (1997-09-02),

13. 5626866 - Drug-containing adhesive composite transdermal delivery device (1997-05-06),

14. 5601839 - Triacetin as a penetration enhancer for transdermal delivery of a basic (1997-02-11),

15. 5585464 - Recombinant antigen for diagnosing rheumatoid arthritis (1996-12-17),

Company Overview

Theratech, Inc. is a biotechnology company based in Salt Lake City, Utah, specializing in the development of innovative therapeutic solutions. The organization focuses on creating advanced drug delivery systems and formulations that enhance the efficacy and safety of medications. With a commitment to addressing unmet medical needs, Theratech leverages its expertise in pharmaceutical sciences and technology to improve patient outcomes across various therapeutic areas, including oncology and chronic diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

36 Patents

#39 in Salt Lake City, UT

#106 in Utah

#9,516 in US

#18,745 in the World

Salt Lake City, UT, United States of America

Theratech, Inc.

Forward Citations = 3,142

24 inventors:

Charles D Ebert (24 out of 44 patents)

Dinesh C Patel (13 out of 13 patents)

Srinivasan Venkateshwaran (12 out of 38 patents)

4. Sonia J Heiber (9 out of 9 patents)

5. Yunik Chang (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Theratech, Inc.. Retrieved from https://idiyas.com/company/theratech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…